WHO ICTRP trial
The Efficacy and Safety of Remimazolam for Sedation During Arteriovenous Fistula…
ChiCTR2500115527 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2500115527 |
|---|---|
| Public title | The Efficacy and Safety of Remimazolam for Sedation During Arteriovenous Fistula Balloon Dilatation in Patients with Uraemia: A Randomised Controlled Trial |
| Scientific title | The Efficacy and Safety of Remimazolam for Sedation During Arteriovenous Fistula Balloon Dilatation in Patients with Uraemia: A Randomised Controlled Trial |
| Primary sponsor | Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | uremia |
| Interventions | Remimazolam Group:Remimazolam-Assisted Sedation;Control group:Normal saline control |
| Registration date | Dec 28, 2025 |
| Target size | Remimazolam Group:40;Control group:40 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: